6Indexed trials
drug · Product Intelligence
Atomoxetine Hydrochloride
Pipeline Intelligence
Atomoxetine Hydrochloride: 6 indexed trials, 2 sponsors; 0 linked Orange Book patents and 4 FDA-linked events where matched.
2Sponsors
0Orange Book patent links
4FDA-linked events
Development evidence
NCT00190879Eli Lilly and Company · adhdPHASE4
NCT00190931Eli Lilly and Company · adhdPHASE4
NCT00485628Eli Lilly and Company · adhdPHASE2
NCT00485875Eli Lilly and Company · adhdPHASE4
NCT00557960Shire · adhdPHASE3
NCT04085172Shire · adhdPHASE4
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALATOMOXETINE HYDROCHLORIDE · 2018-02-23
FDA_APPROVALATOMOXETINE HYDROCHLORIDE · 2017-05-30
FDA_APPROVALATOMOXETINE HYDROCHLORIDE · 2017-05-30
FDA_APPROVALATOMOXETINE HYDROCHLORIDE · 2010-09-16
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.